Kyung Dong Pharmaceutical Dividends and Buybacks
Dividend criteria checks 2/6
Kyung Dong Pharmaceutical is a dividend paying company with a current yield of 5.11%.
Key information
5.1%
Dividend yield
0.8%
Buyback Yield
| Total Shareholder Yield | 5.9% |
| Future Dividend Yield | n/a |
| Dividend Growth | 1.8% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 148% |
Recent dividend and buyback updates
Recent updates
Kyung Dong Pharmaceutical (KOSDAQ:011040) Is Posting Healthy Earnings, But It Is Not All Good News
Mar 30
Is Kyung Dong Pharmaceutical (KOSDAQ:011040) A Risky Investment?
Mar 07Consider This Before Buying Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040) For The 1.9% Dividend
Feb 18
Does Kyung Dong Pharmaceutical's (KOSDAQ:011040) Share Price Gain of 27% Match Its Business Performance?
Feb 03Does Kyung Dong Pharmaceutical's (KOSDAQ:011040) Statutory Profit Adequately Reflect Its Underlying Profit?
Jan 19Kyung Dong Pharmaceutical Co., Ltd.'s (KOSDAQ:011040) Dismal Stock Performance Reflects Weak Fundamentals
Jan 04How Much Of Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040) Do Insiders Own?
Dec 20We Think Kyung Dong Pharmaceutical (KOSDAQ:011040) Can Manage Its Debt With Ease
Dec 05Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A011040 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: A011040 has only been paying a dividend for 6 years, and since then payments have not increased.
Dividend Yield vs Market
| Kyung Dong Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A011040) | 5.1% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A011040) (up to 3 years) | n/a |
Notable Dividend: A011040's dividend (5.11%) is higher than the bottom 25% of dividend payers in the KR market (1.2%).
High Dividend: A011040's dividend (5.11%) is in the top 25% of dividend payers in the KR market (3.88%)
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (148%), A011040's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: A011040 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/18 09:18 |
| End of Day Share Price | 2025/05/16 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kyung Dong Pharmaceutical Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hong-Sik Jeong | LS Securities Co., Ltd. |
| Tae Gi Ha | SK Securities Co., Ltd. |